Amid all the hype over the federal health care law before the Supreme Court, you might have missed this even more relevant news: The high court rejected an appeals court ruling allowing genes to be patented. The case involves two genes linked to breast and ovarian cancer, patented by Myriad Genetics Inc.
The ruling is not a final decision, but sends the case back down to the district court for further action.
In a victory for biotechnology companies, a federal appeals court ruled Friday that human genes can be patented. Odds are pretty good the case will make its way to the Supreme Court, and it’s possible the justices will rule the other way, so this is not a done deal — but until then, it seems companies can own the exclusive right to use human genes.
The genetic tests our writer took to determine what kinds of illnesses he might have
By Meryl RothsteinPosted 08.03.2005 at 3:15 pm 0 Comments
We charged one worrywart writer, Michael Rosenwald, with getting as many different DNA tests as he could to find out what his future—or, more specifically, his genes—had in store for him. In a search for everything from cancer to narcolepsy, Rosenwald sent blood samples or cheek swabs to genetic-testing labs across the country. The DNA in the harvested cells was then extracted from the cells’ nuclei to undergo PCR amplification, essentially molecular photocopying.